Natixis Has Decreased Potash Sask (POT) Stake By $740,411; West Pharmaceutical Services (WST) Sentiment Is 1.33

February 23, 2018 - By Marie Mckinney

Natixis decreased Potash Corp Sask Inc (POT) stake by 63.99% reported in 2017Q3 SEC filing. Natixis sold 38,969 shares as Potash Corp Sask Inc (POT)’s stock declined 11.27%. The Natixis holds 21,926 shares with $421,000 value, down from 60,895 last quarter. Potash Corp Sask Inc now has $17.58B valuation. The stock increased 0.54% or $0.11 during the last trading session, reaching $20.65. About 10.33M shares traded or 346.65% up from the average. Nutrien Ltd. (NYSE:POT) has risen 0.06% since February 23, 2017 and is uptrending. It has underperformed by 16.64% the S&P500.

West Pharmaceutical Services, Inc. manufactures and sells packaging components and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company has market cap of $6.39 billion. The companyÂ’s Proprietary Products segment offers stoppers and seals for injectable packaging systems; and syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies. It has a 43.23 P/E ratio. It also provides drug containment solutions, including CZ vials, syringes, and cartridges; and self-injection systems, as well as specialized testing services for drug packaging, devices, and administration systems.

Since January 1, 0001, it had 0 buys, and 1 insider sale for $2.08 million activity.

Analysts await West Pharmaceutical Services, Inc. (NYSE:WST) to report earnings on April, 26. They expect $0.68 earnings per share, up 13.33% or $0.08 from last year’s $0.6 per share. WST’s profit will be $50.49M for 31.63 P/E if the $0.68 EPS becomes a reality. After $0.64 actual earnings per share reported by West Pharmaceutical Services, Inc. for the previous quarter, Wall Street now forecasts 6.25% EPS growth.

The stock decreased 0.84% or $0.73 during the last trading session, reaching $86.03. About 137,119 shares traded. West Pharmaceutical Services, Inc. (WST) has risen 33.75% since February 23, 2017 and is uptrending. It has outperformed by 17.05% the S&P500.

Kistler holds 2.61% of its portfolio in West Pharmaceutical Services, Inc. for 64,956 shares. Select Equity Group L.P. owns 3.44 million shares or 2.51% of their US portfolio. Moreover, Ami Asset Management Corp has 2.29% invested in the company for 336,102 shares. The New York-based Sandhill Capital Partners Llc has invested 1.89% in the stock. Hermes Investment Management Ltd, a United Kingdom-based fund reported 908,655 shares.

Natixis increased Select Sector Spdr Tr (XLK) stake by 211,572 shares to 1.16 million valued at $68.14 million in 2017Q3. It also upped Healthcare Rlty Tr (NYSE:HR) stake by 17,607 shares and now owns 24,545 shares. Pnm Res Inc (NYSE:PNM) was raised too.

Among 24 analysts covering Potash Corp (NYSE:POT), 12 have Buy rating, 5 Sell and 7 Hold. Therefore 50% are positive. Potash Corp had 73 analyst reports since August 4, 2015 according to SRatingsIntel. Macquarie Research downgraded the stock to “Underperform” rating in Monday, September 21 report. As per Wednesday, August 30, the company rating was maintained by Cowen & Co. On Wednesday, October 21 the stock rating was maintained by RBC Capital Markets with “Sector Perform”. The rating was downgraded by Stifel Nicolaus on Tuesday, May 31 to “Hold”. The rating was maintained by Stifel Nicolaus with “Buy” on Thursday, August 10. Vertical Research downgraded the shares of POT in report on Thursday, April 21 to “Hold” rating. The firm earned “Neutral” rating on Monday, October 31 by Atlantic Securities. The stock of Nutrien Ltd. (NYSE:POT) has “Buy” rating given on Thursday, July 27 by RBC Capital Markets. The stock has “Underweight” rating by Atlantic Securities on Friday, March 11. The company was maintained on Tuesday, June 20 by RBC Capital Markets.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Marie Mckinney

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Recent Posts